Dante Labs Partnering with The Renato Dulbecco Foundation to advance personalized medicines for cancer, COVID-19 and rare diseases
NEW YORK, Feb. 18, 2022 (GLOBE NEWSWIRE) — Dante Labs, a global leader in genomics and precision medicine, today announced it has partnered with The Renato Dulbecco Foundation to deliver more personalized therapies in rare diseases, oncology and COVID-19. Protelica, the groundbreaking US biotechnology company, has licensed its library of billions of pronectines nanoantibodies and […]
Read More